Buys | $203,209 | 2 | 67 |
Sells | $18,410 | 1 | 33 |
Quinn Anthony G. | director | 2 | $203,209 | 0 | $0 | $203,209 |
Paone Antoinette | CHIEF OPERATING OFFICER | 0 | $0 | 1 | $18,410 | $-18,410 |
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Over the last 12 months, insiders at Generation Bio Co. have bought $203,209 and sold $18,410 worth of Generation Bio Co. stock.
On average, over the past 5 years, insiders at Generation Bio Co. have bought $34.8M and sold $14.74M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Quinn Anthony G. (director) — $203,209.
The last purchase of 85,000 shares for transaction amount of $82,450 was made by Quinn Anthony G. (director) on 2025‑01‑13.
2025-01-13 | Quinn Anthony G. | director | 85,000 0.1322% | $0.97 | $82,450 | -25.71% | ||
2025-01-10 | Quinn Anthony G. | director | 125,791 0.1948% | $0.96 | $120,759 | -25.78% | ||
2024-07-01 | Sale | Paone Antoinette | CHIEF OPERATING OFFICER | 6,719 0.0099% | $2.74 | $18,410 | -15.37% | |
2024-01-02 | Sale | Samayoa Phillip | CHIEF STRATEGY OFFICER | 2,445 0.0032% | $1.62 | $3,961 | +34.14% | |
2024-01-02 | Sale | Paone Antoinette | CHIEF OPERATING OFFICER | 2,445 0.0032% | $1.62 | $3,961 | +34.14% | |
2023-12-08 | Appelhans Dannielle | director | 8,000 0.0127% | $1.79 | $14,339 | +46.49% | ||
2023-12-04 | Rowland Charles A Jr | director | 150,000 0.2255% | $1.50 | $225,000 | +65.23% | ||
2023-12-04 | Appelhans Dannielle | director | 12,000 0.018% | $1.50 | $18,000 | +65.23% | ||
2023-12-01 | Rowland Charles A Jr | director | 192,960 0.2723% | $1.31 | $252,778 | +80.22% | ||
2023-12-01 | Nicholson Donald William | director | 100,000 0.1551% | $1.44 | $144,000 | +80.22% | ||
2023-12-01 | Quinn Anthony G. | director | 88,495 0.1344% | $1.41 | $124,778 | +80.22% | ||
2023-08-23 | Sale | Paone Antoinette | CHIEF OPERATING OFFICER | 3,116 0.0046% | $4.93 | $15,362 | -44.22% | |
2023-07-03 | Sale | Samayoa Phillip | CHIEF STRATEGY OFFICER | 3,116 0.0054% | $5.29 | $16,484 | -41.19% | |
2023-04-25 | Sale | Paone Antoinette | CHIEF OPERATING OFFICER | 2,914 0.0049% | $4.61 | $13,434 | -27.77% | |
2023-01-26 | Sale | Paone Antoinette | CHIEF OPERATING OFFICER | 2,695 0.0044% | $5.56 | $14,984 | -26.23% | |
2023-01-10 | Sale | Paone Antoinette | CHIEF OPERATING OFFICER | 1,865 0.003% | $4.57 | $8,523 | -8.80% | |
2023-01-09 | Sale | Samayoa Phillip | CHIEF STRATEGY OFFICER | 1,865 0.0035% | $5.11 | $9,530 | -6.05% | |
2022-10-27 | Sale | Paone Antoinette | CHIEF OPERATING OFFICER | 2,914 0.0051% | $5.03 | $14,657 | -5.45% | |
2022-09-29 | Sale | Paone Antoinette | CHIEF OPERATING OFFICER | 2,828 0.0049% | $5.24 | $14,819 | -5.30% | |
2022-03-09 | Nicholson Donald William | 8,126 0.0137% | $4.71 | $38,273 | +14.72% |
Quinn Anthony G. | director | 299286 0.4481% | $143,657.28 | 3 | 0 | +80.22% |
Invus Public Equities, L.P. | 10 percent owner | 2814191 4.2133% | $1.35M | 1 | 0 | +47.36% |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10 percent owner | 2112546 3.1628% | $1.01M | 1 | 0 | +47.36% |
Seybold William | 10 percent owner | 1918819 2.8728% | $921,033.12 | 1 | 0 | +47.36% |
Zone Healthcare Holdings, LLC | 10 percent owner | 1918819 2.8728% | $921,033.12 | 1 | 0 | +47.36% |
$14,315,062 | 61 | -6.21% | $32.26M | |
$22,186,116 | 57 | -43.73% | $36.64M | |
$53,490,060 | 55 | 19.35% | $29.82M | |
$23,895,365 | 34 | -37.28% | $36.88M | |
$1,295,471 | 17 | 21.79% | $25.28M |
Increased Positions | 40 | +48.19% | 4M | +7.28% |
Decreased Positions | 31 | -37.35% | 5M | -9.81% |
New Positions | 16 | New | 3M | New |
Sold Out Positions | 13 | Sold Out | 4M | Sold Out |
Total Postitions | 92 | +10.84% | 54M | -2.53% |
Price T Rowe Associates Inc /Md/ | $5,382.00 | 13.85% | 9.28M | -72,531 | -0.78% | 2024-12-31 |
Atlas Venture Life Science Advisors, Llc | $4,802.00 | 12.36% | 8.28M | 0 | 0% | 2024-12-31 |
Fmr Llc | $2,683.00 | 6.91% | 4.63M | -694,221 | -13.05% | 2024-12-31 |
Blackrock, Inc. | $2,006.00 | 5.16% | 3.46M | +43,067 | +1.26% | 2024-12-31 |
Bank Of America Corp /De/ | $1,739.00 | 4.47% | 3M | +14,647 | +0.49% | 2024-12-31 |
Siren, L.L.C. | $1,730.00 | 4.45% | 2.98M | 0 | 0% | 2024-12-31 |
Vanguard Group Inc | $1,532.00 | 3.94% | 2.64M | +6,274 | +0.24% | 2024-12-31 |
Jefferies Financial Group Inc. | $1,312.00 | 3.38% | 2.26M | +2M | New | 2024-12-31 |
Ecor1 Capital, Llc | $1,187.00 | 3.06% | 2.05M | 0 | 0% | 2024-12-31 |
Baker Bros. Advisors Lp | $1,128.00 | 2.9% | 1.94M | 0 | 0% | 2024-12-31 |